NIH-funded research R01 grant

Using phage-polymer nanoparticles to treat stubborn wound infections

Official title: Phage-Polymer Nanoparticles for Treatment of Antibiotic-Recalcitrant Wound Biofilm Infections

Funded at University of Massachusetts Amherst · NIH-11224675 · Data updated 2026-11-12

This study is testing a new treatment using tiny particles that combine special viruses and materials to help heal stubborn wounds caused by bacteria that don't respond to regular antibiotics, and it’s designed for patients with chronic infections.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Massachusetts Amherst
NIH-funded
Lab location1 site (Hadley, United States)
Project startJune 6, 2025
Project endMay 31, 2030
Funding year2025
Award (this year)$593,860
NIH project number1R01AI186027-01A1
Project IDNIH-11224675 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients with chronic wounds or infections that have not responded to traditional antibiotic therapies.

Less likely to help

Patients with infections that are not caused by antibiotic-resistant bacteria may not receive benefit from this research.

What this research studies

This research focuses on developing innovative nanoparticles that combine phages and polymers to effectively treat wound infections caused by antibiotic-resistant bacteria. By creating polymer-phage conjugates, the study aims to enhance the ability of phages to penetrate and eradicate biofilms that are typically resistant to standard antibiotic treatments. The approach involves engineering new polymers that can encapsulate phages, allowing for improved delivery and efficacy against these challenging infections. Patients with chronic wounds or infections that do not respond to conventional antibiotics may benefit from this novel treatment strategy.

Why it matters

Potential benefit: If successful, this research could provide a new and effective treatment option for patients suffering from antibiotic-resistant wound infections.

How similar studies have gone: Previous studies have shown promising results using similar phage therapy approaches, indicating potential for success in this novel application.

Where this research is happening

  • University of Massachusetts Amherst
    Hadley, United States
    Active

Researchers

  • Principal investigator: Rotello, Vincent M. — University of Massachusetts Amherst
  • Study coordinator: Rotello, Vincent M.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.